Kerry Group (KRZ)
Irish Exchange · Ireland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 99.60 |
|---|---|
| 52-week range | 64.30 – 99.60 |
| Return, 1 month / 3 months | +16.7% / +21.2% |
| Return, 1 year / 3 years | +25.6% / +43.4% |
| Trend | Uptrend |
| RSI (14) | 83 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -22.8% |
| Average daily value traded | 30.15M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kerry Group is an Irish food and nutrition company based in Tralee, County Kerry. It makes ingredient and flavour systems, taste solutions and nutritional products for food and beverage manufacturers around the world, and it also supplies consumer foods such as dairy products and chilled foods to shoppers in Ireland and Britain. Its customers range from large international food and drink brands to retailers and foodservice operators, and the group serves markets across Europe, the Americas and Asia.
On this site Kerry Group appears as a stock on the Irish Exchange (Ireland), code KRZ, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kerry Group (KRZ) trades on the Irish Exchange in Ireland. It last closed at EUR 99.60 on 22 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 2 of 21 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.6% and over the last three months it rose 21.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Irish Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 28.5% | ||
| From 52-week high | 0.0% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 21.2% | ||
| 6-month return | 47.6% | ||
| 12-month return, skipping the last month | 7.6% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.8% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 30.15M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.2% |
|---|---|
| 1 month | +16.7% |
| 3 months | +21.2% |
| 6 months | +47.6% |
| 1 year | +25.6% |
| 3 years | +43.4% |
| 5 years | −9.5% |
Signals
| 50-day / 200-day average | 86.14 / 77.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Apr 2025 | EUR 0.8900 |
| 10 Oct 2024 | EUR 0.3810 |
| 11 Apr 2024 | EUR 0.8080 |
| 12 Oct 2023 | EUR 0.3460 |
| 13 Apr 2023 | EUR 0.7340 |
| 13 Oct 2022 | EUR 0.3140 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Irish Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.